PPIs may not reduce cancer risks

Long-term pharmacological gastric acid suppression may not reduce the risk of oesophageal cancer in patients with reflux disease, UK data has suggested.

Comparison of 809 cases of newly diagnosed oesophageal or gastric cancer with 10,000 controls highlighted a five-fold increased risk of oesophageal adenocarcinoma among patients who had taken a proton pump inhibitor (PPI) or H2 blocker for more than three years.  

This risk was only seen in patients with reflux symptoms, oesophagitis, Barrett’s oesophagus or hiatal hernia. Patients with peptic ulcers or gastroduodenal symptoms had no increased risk.  

West Sussex GP Dr Jim Price, a member of the Primary Care Society for Gastroenterology, said the findings were surprising. 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Woman holding face in pain

Should GPs treat patients presenting with dental problems?

The MDU's Dr Kathryn Leask considers what GPs should do if a patient presents with...

Conservative Party leadership candidate and foreign secretary Liz Truss

Liz Truss vows to resolve GP pension tax crisis if she becomes prime minister

Liz Truss has affirmed her commitment to resolving the GP pensions crisis but has...

Baby receiving a vaccine in their thigh

JCVI advises changes to routine childhood and HPV immunisation schedules

The Joint Committee on Vaccination and Immunisation (JCVI) has recommended a change...

GP consultation

General practice delivering 'up to double the appointments it is paid for'

General practice in England may be delivering as many as double the number of appointments...

Sign outside BMA House

GP suicide sparks calls for measures to protect doctors from spiralling workloads

The government and policymakers must do more to safeguard doctors and NHS staff from...

Talking General Practice logo

Podcast: Living with long COVID

In August we’re bringing you some of the best interviews from series one of the podcast....